Roquefort Therapeutics Acquires Oncology Asset, Raises £8.5 Million, and Admits to AIM

Fieldfisher has advised SP Angel Corporate Finance LLP and Shard Capital Partners LLP, acting as Nomad and Joint Brokers; Reynolds Porter Chamberlain LLP has acted for…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here